Investors & advisors
Organize market-access diligence around the questions that matter.Diligence with source and review status.
Compare product, company, country, readiness, and risk context while keeping source and review status visible.Product, company, country, readiness, and risk context—without investment claims.
Start a ProjectWorkspace access is reviewed.
Who this is for
Who should use GHMAP for investors
- 01
Investors reviewing healthcare product, company, or market-expansion assumptions.
- 02
Diligence teams comparing source status, evidence gaps, and country-entry uncertainty.
- 03
Advisors organizing market-access risk questions before an investment memo or committee discussion.
Problems GHMAP helps with
Investors market-access problems GHMAP can organize
- 01
Reviewing market-access risk across target countries
- 02
Comparing launch readiness and unresolved assumptions
- 03
Identifying evidence gaps before diligence reliance
- 04
Understanding country expansion assumptions
- 05
Separating source status from investment conclusions
What GHMAP organizes
A source-status-aware workspace for market-access review.
GHMAP keeps market-access records and open questions structured for review, tracking, and handoff.
Countries
Products
Stakeholders
Regulatory questions
Reimbursement questions
Evidence gaps
Source status
Review status
Next actions
Meeting and request tracking
Example workflow
How investors can move from request to reviewed next actions.
Submit company, product, or sector context
Select markets and assumptions to review
GHMAP structures source gaps and launch-readiness questions
Professional review needs stay visible
A diligence-ready market-access question set can be prepared
After request
What happens after you request a demo
- 01
The requester receives a reference number.
- 02
The requester receives an email when email delivery is configured.
- 03
The request can be tracked through Track Request using the reference number and matching email.
- 04
GHMAP reviews fit and may request additional information.
- 05
Workspace access remains invite-only and reviewed.
Start your market access project as investors.
Use the request-demo flow to share role, organization, product or sector interest, countries, and objective. GHMAP will review fit before any workspace access.
Start a ProjectProfessional review is required before business use. Do not submit patient data.


